(THN3)Targeted Hypoglossal Neurostimulation Study #3
Research payments
$431,140
Through program year 2025, $431,140 in research payments was reported against (THN3)Targeted Hypoglossal Neurostimulation Study #3, across 72 payments, paid by LivaNova USA, Inc..
- Paid by
- LivaNova USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,017 | 1 |
| 2024 | Research | $129,785 | 22 |
| 2023 | Research | $126,892 | 18 |
| 2022 | Research | $173,446 | 31 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mitchell Miller Clearwater, FL Named on 18 payments
- Paul Schalch La Mesa, CA Named on 11 payments
- Brian Weeks San Diego, CA Named on 7 payments
- Vseolod Polotsky Baltimore, MD Named on 6 payments
- Samuel Mickelson Atlanta, GA Named on 5 payments
- Ofer Jacobowitz Tarrytown, NY Named on 3 payments
- Nathan Nachlas Boca Raton, FL Named on 3 payments
- Kevin Trice Evansville, IN Named on 2 payments
- Martin Hopp Los Angeles, CA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.